524 related articles for article (PubMed ID: 16769104)
1. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
[TBL] [Abstract][Full Text] [Related]
2. Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study.
Clough KB; Ladonne JM; Nos C; Renolleau C; Validire P; Durand JC
Gynecol Oncol; 1999 Mar; 72(3):411-7. PubMed ID: 10053115
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy in carcinoma of the fallopian tube.
Barakat RR; Rubin SC; Saigo PE; Lewis JL; Jones WB; Curtin JP
Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320
[TBL] [Abstract][Full Text] [Related]
5. [Second-look in ovarian cancer: laparoscopy or laparotomy?].
Russo A; Cirelli G; Cassese E; Delli Ponti D; Sgambato R; Cecere F; Zarcone R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):146-54. PubMed ID: 11526711
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
7. [Technique and preliminary results in second-look laparoscopy in epithelial malignant ovarian tumors].
Canis M; Chapron C; Mage G; Pouly JL; Wattiez A; Bassil S; Raymond F; Bruhat MA
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(6):655-63. PubMed ID: 1430912
[TBL] [Abstract][Full Text] [Related]
8. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
Obermair A; Sevelda P
Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
[TBL] [Abstract][Full Text] [Related]
9. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
[TBL] [Abstract][Full Text] [Related]
10. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
11. Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer.
Paulsen T; Kaern J; Kjaerheim K; Haldorsen T; Tropé C
Gynecol Oncol; 2006 Sep; 102(3):447-52. PubMed ID: 16516277
[TBL] [Abstract][Full Text] [Related]
12. The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.
Alvarez Secord A; Sayer R; Snyder SA; Broadwater G; Rodriguez GC; Berchuck A; Blackwell K
Gynecol Oncol; 2004 Jul; 94(1):74-9. PubMed ID: 15262122
[TBL] [Abstract][Full Text] [Related]
13. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Fagotti A; Ferrandina G; Fanfani F; Ercoli A; Lorusso D; Rossi M; Scambia G
Ann Surg Oncol; 2006 Aug; 13(8):1156-61. PubMed ID: 16791447
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.
Janco JM; Hacker MR; Konstantinopoulos PA; Cannistra SA; Awtrey CS
J Minim Invasive Gynecol; 2011; 18(5):629-33. PubMed ID: 21803662
[TBL] [Abstract][Full Text] [Related]
15. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
[TBL] [Abstract][Full Text] [Related]
16. Second-look laparoscopy prior to proposed second-look laparotomy.
Piver MS; Lele SB; Barlow JJ; Gamarra M
Obstet Gynecol; 1980 May; 55(5):571-3. PubMed ID: 6445047
[TBL] [Abstract][Full Text] [Related]
17. Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseases.
Fujiwara K; Yamauchi H; Yoshida T; Suzuki S; Oda T; Kohno I
Gynecol Oncol; 1998 Aug; 70(2):231-5. PubMed ID: 9740696
[TBL] [Abstract][Full Text] [Related]
18. ["Second-look" surgery and diagnostic laparoscopy in the combined and comprehensive therapy of patients with ovarian cancer].
Gulo EI; Maksimov SIa; Livshits MA; Shcherbakov AM
Vopr Onkol; 1998; 44(2):205-10. PubMed ID: 9615829
[TBL] [Abstract][Full Text] [Related]
19. What is the role of reassessment laparoscopy in the management of gynecologic cancers in 1995?
Casey AC; Farias-Eisner R; Pisani AL; Cirisano FD; Kim YB; Muderspach L; Futoran R; Leuchter RS; Lagasse LD; Karlan BY
Gynecol Oncol; 1996 Mar; 60(3):454-61. PubMed ID: 8774657
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
